Business Description
HighTide Therapeutics Inc
ISIN : KYG4568L1023
Description
HighTide Therapeutics Inc is a biopharmaceutical company specializing in the discovery, development and commercialization of multifunctional, multi-targeted therapies for the treatment of metabolic and digestive diseases. The company has developed a product pipeline of five product candidates in-house, covering nine indications in metabolic and digestive diseases among which, five are at clinical-stage. The Core Product, HTD1801 (berberine ursodeoxycholate), a new molecular entity, is a gut-liver anti-inflammatory metabolic modulator which targets multiple pathways pivotal to metabolic regulation, including those associated with metabolic and digestive diseases.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 44.77 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.23 | |||||
| 9-Day RSI | 44.68 | |||||
| 14-Day RSI | 38.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.76 | |||||
| Quick Ratio | 9.76 | |||||
| Cash Ratio | 9.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -116.09 | |||||
| ROIC % | -81.42 | |||||
| ROC (Joel Greenblatt) % | -11284.32 | |||||
| ROCE % | -408.6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.36 | |||||
| Price-to-Tangible-Book | 3.36 | |||||
| EV-to-EBIT | -1.8 | |||||
| EV-to-EBITDA | -1.8 | |||||
| EV-to-FCF | -6.92 | |||||
| Price-to-Net-Current-Asset-Value | 3.43 | |||||
| Price-to-Net-Cash | 3.66 | |||||
| Earnings Yield (Greenblatt) % | -55.56 | |||||
| FCF Yield % | -10.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HighTide Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | |||
| EPS (TTM) (HK$) | -1.996 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 38.97 | ||
| 14-Day ATR (HK$) | 0.636895 | ||
| 20-Day SMA (HK$) | 5.048 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (HK$) | 4 - 13.18 | ||
| Shares Outstanding (Mil) | 514.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HighTide Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HighTide Therapeutics Inc Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
HighTide Therapeutics Inc Frequently Asked Questions
What is HighTide Therapeutics Inc(HKSE:02511)'s stock price today?
The current price of HKSE:02511 is HK$5.01. The 52 week high of HKSE:02511 is HK$13.18 and 52 week low is HK$4.00.
When is next earnings date of HighTide Therapeutics Inc(HKSE:02511)?
The next earnings date of HighTide Therapeutics Inc(HKSE:02511) is .
Does HighTide Therapeutics Inc(HKSE:02511) pay dividends? If so, how much?
HighTide Therapeutics Inc(HKSE:02511) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers